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Raman Spectroscopy of
Conformational Changes in
Membrane-Bound Sodium
Potassium ATPase
In this investigation we assess the potential of Raman spectroscopy as a tool for probing confor-
mational changes in membrane-spanning proteins — in this case, the sodium potassium adenosine
triphosphatase (Na+,K+-ATPase). Spectral analysis of protein-lipid complexes is complicated by the
presence of a lipidic environment, rendering the amide I spectral region difficult to analyze. We
have therefore focused on spectral changes in the disulfide region arising from cysteine (Cys)
cross-linking and the tyrosine (Tyr) Fermi doublet region arising from changes in Tyr hydrogen
bonding environment. Specifically, we have studied the conformational changes in the Na+,K+-
ATPase undergoing the E2→ E1 transition as controlled by Na+. These conformational changes
were compared to the E1 conformation stabilized by controlled proteolytic digestion. Our results
show that controlled digestion promoting the E1 conformation leads to changes in cross-linking
between Cys residues as well as changes in the Tyr hydrogen bonding environment. In contrast,
Na+ binding, which also promotes the E1 conformation, does not lead to any changes in these
spectral regions. This demonstrates that the functional E1 state of the Na+,K+-ATPase stabilized by
N-terminal truncation differs from that induced by Na+ binding, and that the N-terminal truncation
leads to changes in protein structure that affect the average hydrophobic environment of protein
Tyr, possibly reflecting changes in the hydrophobic coupling between protein and membrane. This
illustrates the stabilizing role of the N-terminal domain under physiological conditions. More gen-
erally, it shows that Raman spectroscopy might be a useful tool in understanding the relationship
between functional states and structural changes in membrane-bound proteins. 
Claus Hélix Nielsen, Salim Abdali, Jens August Lundbæk, and Flemming Cornelius
odium potassium adenosine triphosphatase (Na+,K+-
ATPase) is a transmembrane protein enzyme member
of the P-type ATPase family (1). The minimal func-
tional unit consists of an -subunit of about 100 kDa and a
-subunit of about 38 kDa (2). The enzyme acts as an elec-
trogenic ion transporter in the plasma membrane of all mam-
malian cells (3). Each reaction cycle of the Na+,K+-ATPase
activity pumps three sodium ions out from the cell in exchange
S
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for two potassium ions under hydroly-
sis of one molecule of adenosine triphos-
phate (ATP). The primary role of
Na+,K+-ATPase is to maintain a low
intracellular sodium concentration and
a high intracellular potassium concen-
tration. In addition to its pumping activ-
ity, the enzyme also has been suggested
to function as a signal-transducing
receptor for cardiotonic steroids (4–6).
Most reaction schemes of Na+,K+-
ATPase are based upon the original
Albers–Post mechanism (7,8) involving
phosphorylated and dephosphorylated
forms of the enzyme, both undergoing
conformational transitions (E1P→E2P
and E2→E1) coupled to ion transloca-
tion steps (for recent reviews, see refer-
ences 9 and 10). In the E1 conformation,
the enzyme has a high affinity for ATP
and binds three cytoplasmic Na+ ions.
In connection with a phosphorylation
reaction in which a conserved aspartate
residue in the enzyme is phosphorylated
to form a high-energy phosphoenzyme
(E1P), three Na+ ions are occluded. This
is followed by a spontaneous transition
to a low-energy E2P form and translo-
cation of Na+ across the membrane. Two
K+ ions are then bound at the extracel-
lular side and become occluded by a
dephosphorylation of the enzyme.
Finally, low-affinity binding of ATP
deoccludes and translocates the two K+
ions. Under physiological conditions,
the E2→E1 transition is part of the
pumping cycle and induced by the pres-
ence of Na+.
The first biochemical evidence for
structural changes between E1 and E2
came from tryptic digestion experiments
using renal Na+,K+-ATPase (11). In the
absence of other ligands than K+ (that
is, in E2), trypsin cleaves at arginine-438
(Arg-438) (T1) and subsequently at
lysine-30 (Lys-30) (T2) in the N-termi-
nal part of the -subunit. In the pres-
ence of Na+ (that is, in E1), T1 is pro-
tected against trypsin, while T2 is cleaved
rapidly followed by a slower cleavage at
Arg-262 (T3). Specific cleavage at T2,
whereby the first 30 amino acids are
removed (N-terminal truncation), sta-
bilizes the enzyme in the E1conforma-
tion and decreases hydrolytic capacity
(Vmax) (11).
The N-terminal region contains a
lysine-rich cluster and is among the most
diverse within P-type ATPases, even
between Na+,K+-ATPase isoforms, and
has been assigned special functional sig-
nificance. Thus, in a series of papers,
Rhoda Blostein and colleagues (12,13)
proposed an autoregulatory role for the
N-terminus, which controls the E1/E2
conformational equilibrium by interdo-
main interactions between the cytoplas-
mic TM2-3 and TM4-5 domains.
Recently, the N-terminus also has been
implicated in the tissue-specific regula-
tion of Na+,K+-ATPase by associated
FXYD-proteins (13).
Unfortunately, a homologous region
to the N-terminus of Na+,K+-ATPase is
missing in the sarco(endo)plasmic retic-
ulum Ca2+-ATPase (SERCA), another
member of the P-type ATPases, for
which structures have been solved at the
molecular level in several different E1
and E2 conformations stabilized by var-
ious ligands (14–19). Key features of
these structures are thought to be shared
by other P-type ATPases (20). One
important feature of the SERCA 3D
structure is the existence of three main
cytoplasmic domains: the nucleotide-
binding N-domain, the phosphoryla-
tion or P-domain, and the actuator, or
A-domain where the N-terminal por-
tion of the A-domain consists of two
short helices and an extension connect-
ing to TM1. Similar structures are
assumed in the Na+,K+-ATPase, but with
an additional third N-terminal helical
segment containing the T2 trypsin diges-
tion site (13,21). Thus, we cannot infer
structural consequences of N-terminal
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Figure 1: Vanadate sensitivity of Na+,K+-ATPase. ATP hydrolysis was measured in 120 mM Na+,
10 mM K+, 2 mM Mg2+, and 1 mM ATP at 23 C using the method of Baginski (52) as described
in Materials and Methods. Data are presented as fractions of the activity in the absence of
vanadate as mean  SD (n = 3). The curves are fit using a one site competition (Hill) model with
K0.5 and nH as free parameters. Effects of tryptic cleavage: control: K0.5 = 2.2 M and nH = 1.13
 0.05 (black); after trypsin treatment: K0.5 = 18.3 M and nH = 1.11  0.06 (red); the two
values being significantly different with p < 0.0001. 
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truncation from homology modeling to
the crystal structures of SERCA. It there-
fore becomes important to see if we can
use other tools for analyzing the role of
the N-terminal on the structural organ-
ization of the Na+,K+-ATPase.
Raman spectroscopy has been used to
monitor the changes of secondary struc-
ture in the Na+,K+-ATPase (the E2→E1
transition induced by changes in the con-
centration of Na+ and K+) occurring in
the amide I region (22,23), but with con-
flicting results. Nabiev and colleagues (22)
associated the E1→E2 transition with an
increase in -helical content of about
10%, whereas Anzenbacher and col-
leagues (23) found a decrease in -heli-
cal content of less than 10%. The prob-
lem that arises when using the amide I
region analysis of membrane-bound pro-
teins is that this region typically shows a
broad spectrum that contains several
spectral contributions from both protein
and lipid components (24). Various sub-
traction procedures can be applied in
order to separate out these components.
These procedures will all significantly
influence the experimental data, but it is
not clear to what extent they can produce
results from which unambiguous quan-
titative conclusions about structural
changes can be drawn (23). Also, integral
membrane proteins undergoing a con-
formational change are likely to perturb
the surrounding lipid bilayer, because the
sequence of conformational state change
might involve changes in protein struc-
ture that affect the protein–lipid bound-
ary (25–28), further complicating inter-
pretation of the amide I region.
In this study, we have therefore inves-
tigated whether other Raman spectral
markers than the amide I region can be
used to trace the E1→E2 transition with-
out subtraction of lipid and buffer sig-
nals. We have focused on markers that
can be assigned to changes in the pro-
tein only and not to eventual changes in
the lipid environment. Specifically, we
have investigated changes in disulfide
bond-stretching vibrations and the
Fermi doublet of tyrosine in shark rec-
tal gland Na+,K+-ATPase.
Disulfide bonds play a critical role in
the folding of many proteins and in the
stabilization of tertiary structures (29).
By threading the rat Na+,K+-ATPase
sequence onto the crystal structure of
the closely related skeletal-muscle sar-
coplasmic recticulum Ca2+ ATPase
(SERCA) structure (14), several cross-
linking cysteine (Cys) sites have been
proposed for the rat Na+,K+-ATPase
(20). A gapped Blast alignment reveals
that all Cys residues in the -subunit of
rat Na+,K+-ATPase (NP 036636) are
conserved in the shark rectal gland
Na+,K+-ATPase -subunit (CAG77578)
investigated here (results not shown).
Raman markers have been described for
the S-S stretching (SS) (30,31) and C-S
stretching (CS) modes (32,33) in the
500 to 700 cm1 region, and we investi-
gate possible changes in this region.
We also have investigated Tyr hydro-
gen bonding environment in E1 and E2
conformers because the shark rectal
gland Na+,K+-ATPase sequence contains
25 Tyr residues. Tyr gives rise to a Fermi
doublet at 825 cm1 and 853 cm1, and
the intensity ratio I853/I825 of the dou-
blet represents the average protonation
state (whether Tyr is an acceptor or
donor for hydrogen bonds) (24). We use
5% glycerol to stabilize protein function
(see Materials and Methods); because
glycerol has a Raman band (C-C stretch)
at 852 cm1 (34), we cannot use the
ratio I853/I825 to quantify the average
strength of the hydrogen-bonding envi-
ronment directly for the tyrosine
residues of Na+,K+-ATPase. Neverthe-
less, we will use the I853/I825 ratio to qual-
itatively monitor possible changes asso-
ciated with the E2→E1 transition.
In the present investigation, we have
compared cation-induced E1 and E2 con-
formations by Raman spectroscopy to
the conformational changes found by
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Figure 2: Stacked Raman spectra of the Na+,K+-ATPase in the 300–1550 cm1 region. (E2): in
the E2 promoting buffer; (black); after tryptic digestion (red); and binding of Na+ (blue). All
spectra represent the average intensity from 60 scans with each 10-s illumination time and 1024
spectral sample points. For band assignments, see text. 
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and 1 mM EDTA at pH 7.0. Then,
trypsin inhibitor was added at 1:10
(wt/wt) (Sigma) as previously described
(51) followed by washing and resuspen-
sion. In the ion-binding experiments,
the E1 conformation was introduced by
addition of 30 mM NaCl to the mem-
brane-bound enzyme in histidine-glyc-
erol buffer, resulting in a rapid transi-
tion to the E1(Na+)3 state (42).
Spectra were recorded independently
at least three times for each type of
experiment. The vanadate sensitivity of
at pH 6.8. E2 samples (1-mL aliquot)
were kept at –20 °C and were brought
to room temperature (23 °C) before fur-
ther manipulations and measurements
took place. In the tryptic digestion
experiments, the E1 conformation was
induced using N-terminal truncation of
the -subunit (43). The membrane-
bound enzyme was incubated with
trypsin (T-1426, Sigma, St. Louis, Mis-
souri) at a trypsin:protein ratio of 1:20
(wt/wt) for 10 min on ice in the pres-
ence of 20 mM histidine, 130 mM NaCl,
N-terminal truncation of the shark
Na+,K+-ATPase. We used incubation
with a K+ free histidine–glycerol buffer
(35,36) as a reference for the enzyme
being in the E2 state because glycerol sta-
bilizes the E2 conformation (37–40) and
preserves activity (41). We then rapidly
incubated with excess Na+ to induce the
transition to E1 as previously described
(42). Finally, we used controlled tryptic
digestion with exposure of the T2 cleav-
age site to stabilize the enzyme in the E1
state (43). We assessed the steady-state
distribution of E1 and E2 using enzyme
sensitivity to inhibition by vanadate, a
transition state analog of inorganic
phosphate that binds preferentially with
the E2 conformer of the enzyme (44–46).
In the following, we first show inhibi-
tion to vanadate to demonstrate the
expected change in the E1/E2 equilib-
rium before and after tryptic digestion.
Then we assign the E2 Raman spectrum.
Finally, we investigate whether spectral
changes induced by tryptic digestion or
Na+ binding are observable as changes
in the 400–700 cm1 disulfide bond-
stretching spectral region and the Tyr
850/830 cm1 doublet bands.
Materials and Methods
Enzyme preparation
Membrane-bound Na+,K+-ATPase (EC
3.6.1.37) from rectal glands of the shark
Squalus acanthias (-subunit nucleotide
sequence number AJ781093) was pre-
pared as previously described (47). This
involves isolation of well-defined mem-
brane fragments by differential centrifu-
gation following treatment of micro-
somes with low concentrations (	0.15%)
of deoxycholate to remove loosely
attached proteins. The final protein:lipid
ratio is about 1:1 (wt/wt), and the spe-
cific ATPase activity at 37 °C and pH 7.4
was measured according to Ottolenghi
(48) to be 1617 mol/mg/h. The protein
stock concentration was determined to
be 4.943 mg/mL according to the Peter-
son modification of the Lowry method
using bovine serum albumin as a stan-
dard (49,50). The stock concentrations
were diluted into 1 mg/mL aliquot sam-
ples before the experiments.
For all experiments, the starting con-
formation E2 was induced using a buffer
with 30 mM histidine and 5% glycerol
Circle 33
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Na+,K+-ATPase activity was measured
in 120 mM Na+, 10 mM K+, 2 mM
Mg2+, and 1 mM ATP at 23 °C, as pre-
viously described (13). For all experi-
ments, hydrolytic activity was checked
before and after Raman measurements
at 23 °C in 130 mM Na+, 20mM K+, 4
mM Mg2+, and 3 mM ATP in 15 mM
histidine (pH 7.4) using the method of
Baginski and colleagues (52).
Raman Spectroscopy
Raman spectra were recorded using Chi-
ralRaman Instrument (BioTools, Wau-
conda, Illinois), which utilizes a 532-nm
solid-state cw laser source (Excel, Quan-
tumLaser, UK), and the charge-coupled
device (CCD) camera mounted on the
system is optimized to spectral detec-
tion between 100 and 2400 cm1. The
resolution of the ChiralRaman is
approximately 5 cm1, determined by
the width of the individual fibers in the
fiber-optic cable at the entrance to the
spectrograph (53). The instrument
simultaneously provides Raman and
Raman optical activity (ROA) spectra;
however, in this study, we made use of
only the Raman spectra. The enzyme
sample was placed in a 120-L quartz
cell, and accumulated spectra were
recorded at 100-mW laser intensity. The
entire recording took 30 min per sam-
ple, corresponding to 180 scans each
with 10 s illumination time followed by
1.5 s darkness. This ensured negligible
induction of heat in the sample (meas-
ured to < 0.1 °C). The Raman spectra
were baseline corrected and displayed
using OriginPro 7.5 (OriginLab,
Northampton, Massachusetts).
Results
E1/E2 Equilibrium After Controlled 
Tryptic Digestion
Orthovanadate is a transition homolog
of inorganic phosphate that binds to the
E2 conformation of the Na+,K+-ATPase
(44); thus, sensitivity to inhibition by
vanadate can be used as a measure of the
steady-state distribution between the E2
and E1 conformations (21,46). Figure 1
shows the vanadate sensitivity of the
Na+,K+-ATPase after tryptic digestion.
After tryptic digestion, the vanadate
inhibition constant K0.5 increased from
about 2.2 M to about 18 M (p <
0.001). This demonstrates that tryptic
digestion decreases sensitivity to vana-
date inhibition and thus shifts the E2/E1
equilibrium toward E1.
In order to assess whether these pro-
teolytically induced conformational
changes and changes due to ion binding
are reflected in the vibrational Raman
spectra, we first describe the reference
E2 spectrum; then we proceed to ana-
lyze the spectral changes associated with
the induced E2→E1transitions.
Band Assignment of the Reference E2
Spectrum
Raman spectra of Na+,K+-ATPase in the
E2 promoting buffer (hereafter referred
to as the E2 comformer) were recorded
(the spectrum labeled E2 in Figure 2) and
contain spectral markers from the mem-
brane fragments and embedded protein
as well as buffer (mainly from buffer
glycerol, because H2O solutions of his-
tidine do not show clear Raman bands
in the considered region (300–1650
cm1) (54). The intensity variation
between different experiments prepared
under the same conditions was < 5%.
This was estimated by scaling spectra
obtained from different samples using
the glycerol peak at 927 cm1 (34) as
scaling reference because this peak has
minimal contribution from the protein
(23,55).
In addition to the 927-cm1 glycerol
peak, several other glycerol bands are
known in the 300–1560 cm1 region
(34) and, to some extent, these bands
overlap with bands arising from the pro-
tein as well as the membrane fragments.
Thus, the following assignment will be
based upon known protein (Na+,K+-
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Figure 3: Overlayed spectra of the disulfide bond vibrational region and Tyr Fermi doublet
region of the Na+,K+-ATPase after tryptic digestion (red) and binding of Na+ (blue), together with
the control E2 spectrum (black). 
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ATPase) and lipid bands (23,24) as well
as known glycerol bands (34).
The 400–500 cm1 region is charac-
terized by two distinguishable peaks at
427 and 495 cm1 and a shoulder
around 550 cm1. The 427-cm1 peak
can be assigned to a glycerol COO rock
vibration (34). We assign the 495-cm1
band as resulting from a combination
of the 510-cm1 vibration from spon-
taneously formed protein disulfide
bonds (56) in the form of gauche-
gauche-gauche bonds (24,57) and a glyc-
erol COO rock vibration at 485 cm1
(34). The 550-cm1 shoulder can be
assigned to protein S-S bonds in trans-
gauche-trans configurations (57).
A peak at 680 cm1 can be attributed
to C-S stretch vibration (58); the peaks
at 825 cm1 and 853 cm1 represent Tyr
Fermi doublet arising from a resonance
between the ring-breathing vibration
and the overtone of the out-of-plane
ring bend vibration of the para-substi-
tuted phenyl ring in Tyr. There is also a
glycerol band known to be at 852 cm1
(34) and the ratio I853/I825 = 1.36.
The peaks at 927 cm1 and 977 cm1
can be assigned to glycerol vibrations,
and the skeletal optical region between
1000 cm1 and 1150 cm1 is character-
ized by a peak at 1060 cm1 accompa-
nied by a shoulder extending up to 1150
cm1. The vibrational modes in this
region are highly sensitive to hydrocar-
bon (lipid) state (59) and the presence
of glycerol (34,60–62). Three lipid bands
contribute to this region (62): the 1064
and 1133 cm1 characteristic of all trans
acyl chain segments, and one at 1090
cm1 arising from acyl chains contain-
ing gauche configurations with a sym-
metric O-P-O stretching band arising
from lipid headgroup phosphate groups
superimposed. However, the presence of
protein-diffuse C-C stretching as well as
glycerol bands (34) in the 1000–1150
cm1 region prevents a quantitative
analysis of this region.
In addition to the skeletal optical
region lipid bands, the amide III band
at 1260 cm1 with a shoulder at 1312
cm1 and the strong band at 1467 cm1
can be assigned to CH2 deformations of
the lipids in the membrane fraction (63)
as well as buffer glycerol (34). Although
the amide III region (C-N stretching) in
principle contains quantitative informa-
tion about secondary structure (such as
the ratio between -helical and -sheet
content), we will not analyze it here due
to the prominent lipid and glycerol com-
ponents in our samples and the ensuing
problems in quantitatively separating
out the protein signal components in
those bands. We also disregard the amide
I region (C=O stretching) in spite of the
spectral difference between E2 and E1
induced by tryptic digestion (Figure 2).
We note the absence of a phenylala-
nine band at 1003 cm1 typically pres-
ent in protein spectra. However, this
band depends upon protein conforma-
tion and might not be visible generally,
as reported for rhodopsin (64).
Changes in Disulfide Vibrational Bands
and Tyr Fermi Doublet Bands Associ-
ated with the E2→E1 Transition After
Either Tryptic Digestion or Ion Binding
In our analysis of changes in the Raman
spectrum upon inducing E2→E1 transi-
tions, we will assume that the buffer
glycerol bands are not affected by any
conformational change in the protein
per se. Figure 2 shows the stacked spec-
tra after tryptic digestion and sodium
binding, together with the E2 spectrum.
The tryptic digestion Raman intensities
are lower than those of the control and
the Na+ incubated samples due to wash
and resuspension. To compare the disul-
fide and Tyr spectral regions from the
tryptic digestion and sodium binding
experiments, we use the glycerol peak at
927 cm1 (65) as a scaling reference. Fig-
ure 3 shows the scaled and superim-
posed spectra between 300 cm1 and
1000 cm1. Tryptic digestion results in
increased intensity between 500 cm1
and 650 cm1 as compared with the E2
spectrum: the 427-cm1 and 495-cm1
peak intensities are both decreased and
broadened and the shoulder around 550
cm1 is more pronounced. This shoul-
der is due to the S-S trans-gauche-trans
configurations of the CS-S
-C
 disul-
fide bridges (30,66). The C-S stretching
at 680 cm1 is decreased and the inten-
sity ratio I850/I830 corresponding to the
Tyr Fermi doublet is increased after tryp-
tic digestion: I850/I830 = 1.43, mirroring
the changes in vanadate sensitivity (Fig-
ure 1). In contrast to the spectrum
obtained upon tryptic digestion, the
addition of Na+ does not reveal any
detectable change in the spectrum.
Discussion
The original distinction between E1 and
E2 was based upon the proposal that one
had cation sites facing the cytoplasm and
the other facing the exterior (7,8). The
first direct evidence for two forms of the
dephosphorylated enzyme came from
divergent responses to digestion of the
enzyme by trypsin (43). Clearly, there
are three cleavage sites and the rate of
hydrolysis is a function of the ionic envi-
ronment as would be expected if Na+
and K+ stabilized alternative conforma-
tions of the enzyme. In the Na+,K+-
ATPase, the E2→E1 transition is rate-
limiting for subsequent steps in the
pump cycle (38), and it is therefore of
special interest to investigate structural
changes associated with this transition
in the Na+,K+-ATPase pump cycle.
Previous spectroscopic studies have
investigated the structural changes asso-
ciated with Na+-induced E2→E1 transi-
tion using circular dicroism (67,68),
infrared spectroscopy (69), and Raman
spectroscopy (22,23) with contradictory
results. Our study shows that no disul-
fide bridges are formed nor does the
average Tyr hydrophobic environment
change upon binding of Na+. Thus, the
Na+-induced E1 form is not associated
with an increased number of covalent
intrasubunit bonds or with large changes
in protein secondary structure compared
with the E2 structure. This is not in con-
trast to the fact that the protein does
undergo conformational changes upon
ion binding; rather, the results support
that this is associated with rotation of
protein domains around few hinge
Disulfide bonds play
a critical role in the
folding of many
proteins and in the
stabilization of
tertiary structures.
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amino acids with very little secondary
structural changes (10). Indeed, it has
recently been suggested that a compact
arrangement of the three cytoplasmic
domains in SERCA is maintained dur-
ing the reaction cycle, and that the
E2→E1 transition must be regarded as
an equilibrium between two compact
states, where the N-domain and A-
domain is not far detached from the P-
domain (15). Thus, in the E1 conforma-
tion, the N-domain docks onto the
P-domain and the A-domain is rotated
45° upward, whereas in the E2 confor-
mation, the A-domain rotates back and
docks onto the P-domain, whereby the
N-domain is slightly displaced.
In SERCA, a key role in controlling the
E2→E1 transition is ascribed to the A-
domain, which includes the N-terminus
and encompasses the three first trans-
membrane helical segments. The most
clear place where the SERCA and the
Na+,K+-ATPase sequences differ is at the
N-terminus, and the initial 30 amino
acids of Na+,K+-ATPase are absent in
SERCA. Also, within Na+,K+-ATPase iso-
forms the N-terminal sequence homol-
ogy is low. Indeed, several investigations
have demonstrated specific functional
significance of the Na+,K+-ATPase N-ter-
minal domain. Originally, Jørgensen and
colleagues (11,70,71) demonstrated that
trypsin cleavage at T2 of the enzyme in
the presence of Na+ stabilized the E1 con-
formation, reduced the catalytic capac-
ity, and decreased the K+-sensitivity of
the dephosphorylation reaction. Others
have demonstrated effects on cation
translocation (72) and transport stoi-
chiometry (73). Subsequently, Blostein’s
group (12,21) used deletion mutants and
isoforms chimeras to investigate the
structural basis for these effects and pro-
posed an autoregulatory role for the N-
terminus in controlling interdomain
interaction between the A-domain and
the large cytoplasmic TM4/5 domain.
Recently, we have demonstrated the
species specificity of this interaction and
suggested interaction of the N-terminus
with the FXYD regulatory proteins (13).
Nevertheless, we still miss structural
information as to the spatial interaction
of the N-terminus with the rest of the -
subunit, especially because we cannot
relate this domain to the crystal struc-
ture of SERCA.
It was, therefore, interesting to see
whether we could monitor changes in
the Raman spectra associated with N-
terminal truncation of the Na+,K+-
ATPase. In the experiments with con-
trolled tryptic digestion, we see a 10-fold
decrease in vanadate sensitivity (Figure
1), indicating E1 stabilization, together
with a marked increase in Raman inten-
sity at 550 cm1. This indicates that
disulfide bridges are formed when the
E1 conformation is stabilized by tryptic
digestion. The fact that disulfide
crosslinks are formed after cleavage at
the T2 site indicates modifications in the
3D packing induced by proteolysis and
is in line with the findings that prote-
olytic fragments of transmembrane
spans (74) cross-link only after diges-
tion (75). Also, the average Tyr hydro-
gen bonding is changed. I850/I830
increases, and although we cannot assess
directly the protonation state of the 25
tyrosine residues due to the glycerol
peak, an increase in I850/I830 can be asso-
ciated with an increased exposure of Tyr
residues to the aqueous surroundings.
Mapping the 25 Tyr residues onto the
SERCA structure reveals a distribution
with about one half of the Tyr residues
in the interfacial regions of the trans-
membrane segments and the other half
distributed in the cytoplasmic regions.
In principle, any change in Tyr exposure
could be due to changes in either group
of Tyr residues; based upon analogy with
SERCA conformational changes, it is
most likely that changes in I850/I830
reflect changes in the transmembrane
Tyr exposure to the aqueous phase,
because the secondary structure of the
cytoplasmic regions appears unaltered
in SERCA upon Ca2+ binding (16).
Thus, the formation of disulfide bonds
induces changes in overall protein struc-
ture — possibly reflecting changes in the
hydrophobic interaction between mem-
brane and protein.
Interestingly, the spectral changes
observed after N-terminal truncation,
which stabilizes the E1 conformation,
seem to result in more profound struc-
tural changes than the E2→E1 confor-
mational change induced by Na+ bind-
ing. Indeed, this might be a result of a
perturbed molecular arrangement
induced by proteolysis, reflecting the sta-
bilization induced by the N-terminal
domain under physiological conditions.
In this connection, it is worth empha-
sizing the autoregulatory function of the
lysine-rich N-terminus, which is pro-
posed to take place by interaction of the
TM2/3 loop of the A-domain with the
cytoplasmic TM4/5 catalytic loop as
controlled by the N-terminus (21).
Taken together, our results show that
the biochemically defined E1 state of
Na+,K+-ATPase does not represent a
unique structural conformation; rather,
the conformation depends upon how
the state is introduced. Specifically, our
results demonstrate that N-terminal
truncation leads to changes in protein
structure that affect the average
hydrophobic environment of protein Tyr
residues, possibly reflecting changes in
the hydrophobic coupling between pro-
tein and membrane. This illustrates the
stabilizing role of the N-terminal
domain under physiological conditions.
More generally, our studies demonstrate
that Raman spectroscopy might be a
useful tool in label-free dissection of pro-
tein conformational changes in
lipid–protein complexes.
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